551 related articles for article (PubMed ID: 23735216)
1. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.
Lee MJ; Pramyothin P; Karastergiou K; Fried SK
Biochim Biophys Acta; 2014 Mar; 1842(3):473-81. PubMed ID: 23735216
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration.
Do TTH; Marie G; Héloïse D; Guillaume D; Marthe M; Bruno F; Marion B
J Steroid Biochem Mol Biol; 2019 Jan; 185():150-162. PubMed ID: 30145227
[TBL] [Abstract][Full Text] [Related]
3. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
[TBL] [Abstract][Full Text] [Related]
4. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.
Campbell JE; Fediuc S; Hawke TJ; Riddell MC
Metabolism; 2009 May; 58(5):651-60. PubMed ID: 19375588
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.
Gathercole LL; Morgan SA; Bujalska IJ; Hauton D; Stewart PM; Tomlinson JW
PLoS One; 2011; 6(10):e26223. PubMed ID: 22022575
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
Bujalska IJ; Durrani OM; Abbott J; Onyimba CU; Khosla P; Moosavi AH; Reuser TT; Stewart PM; Tomlinson JW; Walker EA; Rauz S
J Endocrinol; 2007 Feb; 192(2):279-88. PubMed ID: 17283228
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity.
Liu L; Wang Y; Wang J; Dong Y; Chang S; Liu X; Lutfy K; Chen H; Friedman TC; Jiang M; Liu Y
Int J Obes (Lond); 2018 Dec; 42(12):1999-2011. PubMed ID: 29568102
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
9. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
10. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.
Espíndola-Antunes D; Kater CE
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1397-403. PubMed ID: 18209879
[TBL] [Abstract][Full Text] [Related]
12. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
13. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.
Morgan SA; Hassan-Smith ZK; Lavery GG
Eur J Endocrinol; 2016 Aug; 175(2):R83-9. PubMed ID: 26957494
[TBL] [Abstract][Full Text] [Related]
14. Distinct response of adipocyte progenitors to glucocorticoids determines visceral obesity via the TEAD1-miR-27b-PRDM16 axis.
Lv Y; Xia F; Yu J; Sheng Y; Jin Y; Li Y; Ding G
Obesity (Silver Spring); 2023 Sep; 31(9):2335-2348. PubMed ID: 37574723
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes.
Bujalska IJ; Quinkler M; Tomlinson JW; Montague CT; Smith DM; Stewart PM
J Mol Endocrinol; 2006 Oct; 37(2):327-40. PubMed ID: 17032748
[TBL] [Abstract][Full Text] [Related]
16. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue.
Bujalska IJ; Hewitt KN; Hauton D; Lavery GG; Tomlinson JW; Walker EA; Stewart PM
Endocrinology; 2008 May; 149(5):2584-91. PubMed ID: 18218694
[TBL] [Abstract][Full Text] [Related]
17. Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue.
Veyrat-Durebex C; Deblon N; Caillon A; Andrew R; Altirriba J; Odermatt A; Rohner-Jeanrenaud F
PLoS One; 2012; 7(3):e34002. PubMed ID: 22479501
[TBL] [Abstract][Full Text] [Related]
18. Metabolic comorbidities in Cushing's syndrome.
Ferraù F; Korbonits M
Eur J Endocrinol; 2015 Oct; 173(4):M133-57. PubMed ID: 26060052
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte GR Inhibits Healthy Adipose Expansion Through Multiple Mechanisms in Cushing Syndrome.
Hayashi R; Okuno Y; Mukai K; Kitamura T; Hayakawa T; Onodera T; Murata M; Fukuhara A; Imamura R; Miyagawa Y; Nonomura N; Otsuki M; Shimomura I
Endocrinology; 2019 Mar; 160(3):504-521. PubMed ID: 30649271
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids regulate adipose tissue protein concentration in a depot- and sex-specific manner.
Hill JL; Solomon MB; Nguyen ET; Caldwell JL; Wei Y; Foster MT
Stress; 2020 Mar; 23(2):243-247. PubMed ID: 31441358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
